143 related articles for article (PubMed ID: 2174826)
1. Specificity of androgen receptors of hepatocellular carcinoma and liver in humans.
Nagasue N; Kohno H; Chang Y; Hayashi T; Nakamura T
Hepatogastroenterology; 1990 Oct; 37(5):474-9. PubMed ID: 2174826
[TBL] [Abstract][Full Text] [Related]
2. [Estrogen and androgen receptors in hepatocellular carcinoma and in noncancerous liver tissue].
Hamazaki K; Miura H; Sakai H; Sato S; Yunoki M; Miichi N; Noda T; Mori M; Orita K
Gan No Rinsho; 1989 Sep; 35(10):1109-13. PubMed ID: 2550681
[TBL] [Abstract][Full Text] [Related]
3. Androgen receptor in cirrhotic liver, adenomatous hyperplastic nodule and hepatocellular carcinoma in the human.
Nagasue N; Yamanoi A; Kohno H; Kimoto T; Chang Y; Taniura H; Uchida M; Nakamura T
Hepatogastroenterology; 1992 Oct; 39(5):455-60. PubMed ID: 1334038
[TBL] [Abstract][Full Text] [Related]
4. Androgen receptor and hepatocarcinogenesis: what do we learn from HCC mouse models?
Zender L; Kubicka S
Gastroenterology; 2008 Sep; 135(3):738-40. PubMed ID: 18692055
[No Abstract] [Full Text] [Related]
5. [Androgen receptor in hepatocellular carcinoma and the surrounding liver tissues in China].
Liang L; Lu M; Huang J
Zhonghua Zhong Liu Za Zhi; 1996 May; 18(3):214-7. PubMed ID: 9387258
[TBL] [Abstract][Full Text] [Related]
6. The clinical and pathogenetic significance of estrogen receptor-beta expression in chronic liver diseases and liver carcinoma.
Iavarone M; Lampertico P; Seletti C; Francesca Donato M; Ronchi G; del Ninno E; Colombo M
Cancer; 2003 Aug; 98(3):529-34. PubMed ID: 12879470
[TBL] [Abstract][Full Text] [Related]
7. Androgen receptor in primary hepatocellular carcinoma and its clinical significance.
Zhang X; He L; Lu Y; Liu M; Huang X
Chin Med J (Engl); 1998 Dec; 111(12):1083-6. PubMed ID: 11263369
[TBL] [Abstract][Full Text] [Related]
8. The Sialyl Lewis X expression in hepatocarcinogenesis: potential predictor for the emergence of hepatocellular carcinoma.
Fujiwara Y; Shimada M; Takenaka K; Kajiyama K; Shirabe K; Sugimachi K
Hepatogastroenterology; 2002; 49(43):213-7. PubMed ID: 11941958
[TBL] [Abstract][Full Text] [Related]
9. [Distribution of androgen receptor in primary liver cancer and its clinical significance].
Cui S; Li G
Zhonghua Zhong Liu Za Zhi; 1995 Jul; 17(4):304-6. PubMed ID: 7587903
[TBL] [Abstract][Full Text] [Related]
10. Intercellular communication and human hepatocellular carcinoma.
Carruba G; Cocciadiferro L; Bellavia V; Rizzo S; Tsatsanis C; Spandidos D; Muti P; Smith C; Mehta P; Castagnetta L
Ann N Y Acad Sci; 2004 Dec; 1028():202-12. PubMed ID: 15650246
[TBL] [Abstract][Full Text] [Related]
11. HGF, MET, and matrix-related proteases in hepatocellular carcinoma, fibrolamellar variant, cirrhotic and normal liver.
Schoedel KE; Tyner VZ; Kim TH; Michalopoulos GK; Mars WM
Mod Pathol; 2003 Jan; 16(1):14-21. PubMed ID: 12527708
[TBL] [Abstract][Full Text] [Related]
12. Hormonal therapy with megestrol in inoperable hepatocellular carcinoma characterized by variant oestrogen receptors.
Villa E; Ferretti I; Grottola A; Buttafoco P; Buono MG; Giannini F; Manno M; Bertani H; Dugani A; Manenti F
Br J Cancer; 2001 Apr; 84(7):881-5. PubMed ID: 11286465
[TBL] [Abstract][Full Text] [Related]
13. [Significance of both nuclear and cytosol androgen receptor (AR) in assessment of AR status in prostate carcinoma and hepatocellular carcinoma].
Lu HP; Gao JH
Ai Zheng; 2003 Feb; 22(2):168-70. PubMed ID: 12600293
[TBL] [Abstract][Full Text] [Related]
14. [Clonal analysis of hepatocellular carcinoma].
Ochiai T; Ueda K; Urata Y; Yamano T; Konishi E; Ogino A; Kawai K; Itoi H; Sonoyama T; Yamagishi H; Oka T; Ashihara T
Gan To Kagaku Ryoho; 1996 Jun; 23 Suppl 2():182-8. PubMed ID: 8678565
[TBL] [Abstract][Full Text] [Related]
15. Expression of oestrogen and growth factor receptors in hepatocellular carcinoma.
Meza-Junco J; Montano-Loza AJ; Gamboa-Dominguez A; Green-Renner D
Clin Oncol (R Coll Radiol); 2007 Dec; 19(10):801-2. PubMed ID: 17822888
[No Abstract] [Full Text] [Related]
16. Increased liver iron stores in patients with hepatocellular carcinoma developed on a noncirrhotic liver.
Turlin B; Juguet F; Moirand R; Le Quilleuc D; Loréal O; Campion JP; Launois B; Ramée MP; Brissot P; Deugnier Y
Hepatology; 1995 Aug; 22(2):446-50. PubMed ID: 7635411
[TBL] [Abstract][Full Text] [Related]
17. [Establishment of an estrogen receptor positive 3'-methyl-4-dimethylaminoazobenzene induced hepatoma cell line of rat and investigation of hormonal therapy].
Kameda H
Hokkaido Igaku Zasshi; 1996 Nov; 71(6):711-26. PubMed ID: 8996840
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of cannabinoid receptors CB1 and CB2 correlates with improved prognosis of patients with hepatocellular carcinoma.
Xu X; Liu Y; Huang S; Liu G; Xie C; Zhou J; Fan W; Li Q; Wang Q; Zhong D; Miao X
Cancer Genet Cytogenet; 2006 Nov; 171(1):31-8. PubMed ID: 17074588
[TBL] [Abstract][Full Text] [Related]
19. Sex hormone receptors in hepatocellular carcinoma. Is there a rationale for hormonal treatment?
Boix L; Bruix J; Castells A; Fuster J; Bru C; Visa J; Rivera F; Rodes J
J Hepatol; 1993 Feb; 17(2):187-91. PubMed ID: 8383159
[TBL] [Abstract][Full Text] [Related]
20. [Expression of growth hormone receptor mRNA in hepatocellular carcinoma and matched para-cancer cirrhotic liver tissue].
Wang HT; Wang J; Ou QJ; Liu XP; Chen S
Ai Zheng; 2002 Feb; 21(2):146-8. PubMed ID: 12479063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
